DURHAM, N.C., Nov. 5, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today that it will report financial results for the third quarter ended September 30, 2013, on Thursday, November 14, 2013, before the market opens. Chimerix's management team will host a live conference call and audio webcast at 8:30 a.m. ET on Thursday, November 14, 2013 to discuss the Company's results in detail.
Help employers find you! Check out all the jobs and post your resume.
